BRAND NEW PRODUCT FROM THIS RANGE
In the aim of providing winemakers with a solution adapted to their needs for an effecient and simple product to use for the MLF management, and after 4 trial campaigns in the Southern and the Northern hemisphere, LAFFORT® launches LACTOENOS® B7 DIRECT.
With this bacterium, LAFFORT® presents to winemakers a tool combining a high malolactic performance in red, white and rose wines with pH ≥ 3,2 and an easy to use product; LACTOENOS® B7 DIRECT can be directly inoculated into the wine.
Derived from its research on malolactic fermentation, LAFFORT has selected different bacterial strains for their oenological aptitudes and has developed production and inoculation procedures specific to each. LAFFORT’s straistrain-production technology combination provides professionals with optimal MLF control at competitive prices.
Which bacterial strain for which wine?
|LACTOENOS® B7 DIRECT||≤ 16%vol.||≥ 3,2||≤ 60mg/L||
|LACTOENOS® SB3 Direct||≤ 15%vol.||
|LACTOENOS® 450 PreAc||≤ 17%vol.||≥ 3,3||≤ 60mg/L||
|LACTOENOS® B16 Standard||≤ 16%vol.||≥ 2,9||≤ 60mg/L||
|Type of inoculation||Step||
|early co-inoculation||24 h after AF start-up.||Saves time and avoids MLF failure. Optimised fermentation management. Reduced production of diacetyl. Reduction of compounds combining SO2 in the wine|
|Late co-inoculation tardive||1010 density||Monopolisation of the ecosystem. Secures a traditional vinification process (AF then MLF).|
After AF, at pressing.
MLF after post AF maceration. MLF in barrels.
|Curative inoculation||Later...||Restarting stuck MLF.